Conversion from cilostazol to OPC-13015 linked to mitigation of cognitive impairment

Satoshi Saito

Presentation information

Oral Session

[O-15] Oral Session 15 Dementia2

Thu. May 20, 2021 9:45 AM - 10:45 AM Room 05 (ICC Kyoto 2F Room B-1)

Chair：Egawa Naohiro(Department of Neurology, Kyoto University Graduate School of Medicine),Washida Kazuo(Department of Neurology, National Cerebral and Cardiovascular Center)

[O-15-4] Conversion from cilostazol to OPC-13015 linked to mitigation of cognitive impairment

^○Satoshi Saito¹, Kaori Shinmyozu², Daisuke Kawakami³, Miho Yamauchi¹, Shuhei Ikeda¹, Yorito Hattori¹, Yamamoto Rintaro³, Naoki Hayakawa², Masafumi Ihara¹ (1.Department of Neurology, National Cerebral and Cardiovascular Center, Japan, 2.Department of Pharmacy, National Cerebral and Cardiovascular Center, 3.Division of Analytical & Measuring Instruments, Shimadzu Corporation)

Abstract password authentication.
Password is written on a pocket program and name badge.